BRENDA - Enzyme Database show
show all sequences of 2.7.8.13

Studies on bacterial cell wall inhibitors. X. Properties of phosph-N-acetylmuramoyl-pentapeptide-transferase in peptidoglycan synthesis of Bacillus megaterium and its inhibition by amphomycin

Tanaka, H.; Oiwa, R.; Matsukura, S.; Inokoshi, J.; Omura, S.; J. Antibiot. 35, 1216-1221 (1982)

Data extracted from this reference:

Inhibitors
Inhibitors
Commentary
Organism
Structure
Amphomycin
-
Bacillus megaterium
Cs+
-
Bacillus megaterium
NH4+
-
Bacillus megaterium
KM Value [mM]
KM Value [mM]
KM Value Maximum [mM]
Substrate
Commentary
Organism
Structure
0.093
-
UDP-MurNAc-pentapeptide
pH 8.5, 25°C, enzyme is not purified
Bacillus megaterium
Metals/Ions
Metals/Ions
Commentary
Organism
Structure
Mg2+
required for maximal activation, optimum concentration 25 mM
Bacillus megaterium
Natural Substrates/ Products (Substrates)
Natural Substrates
Organism
Commentary (Nat. Sub.)
Natural Products
Commentary (Nat. Pro.)
Organism (Nat. Pro.)
Reversibility
UDP-NAc-muramoyl-pentapeptide + acceptor
Bacillus megaterium
-
UMP + acceptor-phospho-NAc-muramoyl-pentapeptide +
-
Bacillus megaterium
r
UDP-NAc-muramoyl-pentapeptide + acceptor
Bacillus megaterium KM / ATCC 13632
-
UMP + acceptor-phospho-NAc-muramoyl-pentapeptide +
-
Bacillus megaterium KM / ATCC 13632
r
Organism
Organism
Primary Accession No. (UniProt)
Commentary
Textmining
Bacillus megaterium
-
-
-
Bacillus megaterium KM / ATCC 13632
-
-
-
Substrates and Products (Substrate)
Substrates
Commentary Substrates
Literature (Substrates)
Organism
Products
Commentary (Products)
Literature (Products)
Organism (Products)
Reversibility
UDP-N-acetylmuramoyl-pentapeptide + [2H]UMP
-
645336
Bacillus megaterium
UMP + [2H]UDP-NAc-muramoyl-pentapeptide
-
645336
Bacillus megaterium
r
UDP-N-acetylmuramoyl-pentapeptide + [2H]UMP
-
645336
Bacillus megaterium KM / ATCC 13632
UMP + [2H]UDP-NAc-muramoyl-pentapeptide
-
645336
Bacillus megaterium KM / ATCC 13632
r
UDP-NAc-muramoyl-pentapeptide + acceptor
-
645336
Bacillus megaterium
UMP + acceptor-phospho-NAc-muramoyl-pentapeptide
-
645336
Bacillus megaterium
r
UDP-NAc-muramoyl-pentapeptide + acceptor
-
645336
Bacillus megaterium KM / ATCC 13632
UMP + acceptor-phospho-NAc-muramoyl-pentapeptide
-
645336
Bacillus megaterium KM / ATCC 13632
r
UDP-NAc-muramoyl-pentapeptide + acceptor
-
645336
Bacillus megaterium
UMP + acceptor-phospho-NAc-muramoyl-pentapeptide +
-
645336
Bacillus megaterium
r
UDP-NAc-muramoyl-pentapeptide + acceptor
-
645336
Bacillus megaterium KM / ATCC 13632
UMP + acceptor-phospho-NAc-muramoyl-pentapeptide +
-
645336
Bacillus megaterium KM / ATCC 13632
r
pH Optimum
pH Optimum Minimum
pH Optimum Maximum
Commentary
Organism
8.5
-
-
Bacillus megaterium
pH Range
pH Minimum
pH Maximum
Commentary
Organism
5.5
9
activity is significantly weaker at values below pH7.5 or over pH 9.0, about 40% of activity maximum at pH 6.5, about 80% of activity maximum at pH 9.0
Bacillus megaterium
Inhibitors (protein specific)
Inhibitors
Commentary
Organism
Structure
Amphomycin
-
Bacillus megaterium
Cs+
-
Bacillus megaterium
NH4+
-
Bacillus megaterium
KM Value [mM] (protein specific)
KM Value [mM]
KM Value Maximum [mM]
Substrate
Commentary
Organism
Structure
0.093
-
UDP-MurNAc-pentapeptide
pH 8.5, 25°C, enzyme is not purified
Bacillus megaterium
Metals/Ions (protein specific)
Metals/Ions
Commentary
Organism
Structure
Mg2+
required for maximal activation, optimum concentration 25 mM
Bacillus megaterium
Natural Substrates/ Products (Substrates) (protein specific)
Natural Substrates
Organism
Commentary (Nat. Sub.)
Natural Products
Commentary (Nat. Pro.)
Organism (Nat. Pro.)
Reversibility
UDP-NAc-muramoyl-pentapeptide + acceptor
Bacillus megaterium
-
UMP + acceptor-phospho-NAc-muramoyl-pentapeptide +
-
Bacillus megaterium
r
UDP-NAc-muramoyl-pentapeptide + acceptor
Bacillus megaterium KM / ATCC 13632
-
UMP + acceptor-phospho-NAc-muramoyl-pentapeptide +
-
Bacillus megaterium KM / ATCC 13632
r
Substrates and Products (Substrate) (protein specific)
Substrates
Commentary Substrates
Literature (Substrates)
Organism
Products
Commentary (Products)
Literature (Products)
Organism (Products)
Reversibility
UDP-N-acetylmuramoyl-pentapeptide + [2H]UMP
-
645336
Bacillus megaterium
UMP + [2H]UDP-NAc-muramoyl-pentapeptide
-
645336
Bacillus megaterium
r
UDP-N-acetylmuramoyl-pentapeptide + [2H]UMP
-
645336
Bacillus megaterium KM / ATCC 13632
UMP + [2H]UDP-NAc-muramoyl-pentapeptide
-
645336
Bacillus megaterium KM / ATCC 13632
r
UDP-NAc-muramoyl-pentapeptide + acceptor
-
645336
Bacillus megaterium
UMP + acceptor-phospho-NAc-muramoyl-pentapeptide
-
645336
Bacillus megaterium
r
UDP-NAc-muramoyl-pentapeptide + acceptor
-
645336
Bacillus megaterium KM / ATCC 13632
UMP + acceptor-phospho-NAc-muramoyl-pentapeptide
-
645336
Bacillus megaterium KM / ATCC 13632
r
UDP-NAc-muramoyl-pentapeptide + acceptor
-
645336
Bacillus megaterium
UMP + acceptor-phospho-NAc-muramoyl-pentapeptide +
-
645336
Bacillus megaterium
r
UDP-NAc-muramoyl-pentapeptide + acceptor
-
645336
Bacillus megaterium KM / ATCC 13632
UMP + acceptor-phospho-NAc-muramoyl-pentapeptide +
-
645336
Bacillus megaterium KM / ATCC 13632
r
pH Optimum (protein specific)
pH Optimum Minimum
pH Optimum Maximum
Commentary
Organism
8.5
-
-
Bacillus megaterium
pH Range (protein specific)
pH Minimum
pH Maximum
Commentary
Organism
5.5
9
activity is significantly weaker at values below pH7.5 or over pH 9.0, about 40% of activity maximum at pH 6.5, about 80% of activity maximum at pH 9.0
Bacillus megaterium
Other publictions for EC 2.7.8.13
No.
1st author
Pub Med
title
organims
journal
volume
pages
year
Activating Compound
Application
Cloned(Commentary)
Crystallization (Commentary)
Engineering
General Stability
Inhibitors
KM Value [mM]
Localization
Metals/Ions
Molecular Weight [Da]
Natural Substrates/ Products (Substrates)
Organic Solvent Stability
Organism
Oxidation Stability
Posttranslational Modification
Purification (Commentary)
Reaction
Renatured (Commentary)
Source Tissue
Specific Activity [micromol/min/mg]
Storage Stability
Substrates and Products (Substrate)
Subunits
Temperature Optimum [°C]
Temperature Range [°C]
Temperature Stability [°C]
Turnover Number [1/s]
pH Optimum
pH Range
pH Stability
Cofactor
Ki Value [mM]
pI Value
IC50 Value
Activating Compound (protein specific)
Application (protein specific)
Cloned(Commentary) (protein specific)
Cofactor (protein specific)
Crystallization (Commentary) (protein specific)
Engineering (protein specific)
General Stability (protein specific)
IC50 Value (protein specific)
Inhibitors (protein specific)
Ki Value [mM] (protein specific)
KM Value [mM] (protein specific)
Localization (protein specific)
Metals/Ions (protein specific)
Molecular Weight [Da] (protein specific)
Natural Substrates/ Products (Substrates) (protein specific)
Organic Solvent Stability (protein specific)
Oxidation Stability (protein specific)
Posttranslational Modification (protein specific)
Purification (Commentary) (protein specific)
Renatured (Commentary) (protein specific)
Source Tissue (protein specific)
Specific Activity [micromol/min/mg] (protein specific)
Storage Stability (protein specific)
Substrates and Products (Substrate) (protein specific)
Subunits (protein specific)
Temperature Optimum [°C] (protein specific)
Temperature Range [°C] (protein specific)
Temperature Stability [°C] (protein specific)
Turnover Number [1/s] (protein specific)
pH Optimum (protein specific)
pH Range (protein specific)
pH Stability (protein specific)
pI Value (protein specific)
Expression
General Information
General Information (protein specific)
Expression (protein specific)
KCat/KM [mM/s]
KCat/KM [mM/s] (protein specific)
737788
Al-Dabbagh
Catalytic mechanism of MraY an ...
Bacillus subtilis 168, Bacillus subtilis
Biochimie
127
249-257
2016
-
1
1
-
1
-
2
1
1
1
-
2
-
7
-
-
-
1
-
-
-
-
12
-
1
-
-
1
1
-
-
-
-
-
1
-
1
1
-
-
1
-
1
2
-
1
1
1
-
2
-
-
-
-
-
-
-
-
12
-
1
-
-
1
1
-
-
-
-
2
2
-
-
-
737580
Moberg
Assessing HTS performance usin ...
Bacillus subtilis 168, Bacillus subtilis
Assay Drug Dev. Technol.
12
506-513
2014
-
2
-
-
-
-
1
-
-
1
-
-
-
4
-
-
-
-
-
-
-
-
4
-
1
-
-
-
1
-
-
-
-
-
-
-
2
-
-
-
-
-
-
1
-
-
-
1
-
-
-
-
-
-
-
-
-
-
4
-
1
-
-
-
1
-
-
-
-
-
-
-
-
-
738596
Ishizaki
Inhibition of the first step i ...
Bacillus subtilis 168, Bacillus subtilis
J. Biol. Chem.
288
30309-30319
2013
-
-
-
-
-
-
3
-
-
-
-
2
-
6
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
-
2
3
-
-
-
-
-
2
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
1
1
-
-
-
725566
Shapiro
A high-throughput, homogeneous ...
Escherichia coli
J. Biomol. Screen.
17
662-672
2012
-
-
-
-
-
-
1
-
-
1
-
-
-
2
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
1
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
690996
Al-Dabbagh
Active site mapping of MraY, a ...
Bacillus subtilis
Biochemistry
47
8919-8928
2008
-
1
1
-
14
-
-
27
-
1
-
-
-
3
-
-
1
-
-
-
15
-
3
-
-
-
-
32
2
1
-
-
-
-
-
-
1
1
-
-
14
-
-
-
-
27
-
1
-
-
-
-
-
1
-
-
15
-
3
-
-
-
-
32
2
1
-
-
-
-
-
-
-
-
692509
Zheng
Genetic analysis of MraY inhib ...
Bacillus subtilis, Escherichia coli
Genetics
180
1459-1466
2008
-
-
1
-
7
-
2
-
-
-
-
2
-
5
-
-
-
-
-
-
-
-
3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
7
-
-
2
-
-
-
-
-
2
-
-
-
-
-
-
-
-
3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
694514
Xu
Synthesis of gem-difluorinated ...
Micrococcus flavus
Org. Biomol. Chem.
6
157-161
2008
-
-
-
-
-
-
1
-
-
-
-
-
-
1
-
-
1
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
1
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
704218
Murakami
A-94964, a novel inhibitor of ...
Enterococcus faecalis, Staphylococcus aureus
J. Antibiot.
61
537-544
2008
-
2
-
-
-
-
2
-
-
-
-
2
-
6
-
-
-
-
-
-
-
-
4
-
2
-
-
-
2
-
-
-
-
-
2
-
2
-
-
-
-
-
2
2
-
-
-
-
-
2
-
-
-
-
-
-
-
-
4
-
2
-
-
-
2
-
-
-
-
2
2
-
-
-
704219
Fujita
A-94964, novel inhibitor of ba ...
Enterococcus faecalis, Staphylococcus aureus
J. Antibiot.
61
545-549
2008
-
2
-
-
-
-
2
-
-
-
-
2
-
3
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
2
-
-
-
-
-
2
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
2
2
-
-
-
676084
Mohammadi
The essential peptidoglycan gl ...
Escherichia coli, Escherichia coli LMC500
Mol. Microbiol.
65
1106-1121
2007
-
-
-
-
-
-
-
-
-
-
1
-
-
2
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
692188
Le Corre
-
Towards new MraY inhibitors: a ...
Bacteria
Eur. J. Org. Chem.
2007
5386-5394
2007
-
1
-
-
-
-
1
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
695173
Kurosu
-
Chemoenzymatic synthesis of Pa ...
Bacteria
Tetrahedron Lett.
48
799-803
2007
-
1
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
675899
Schouten
Fluorescent reagents for in vi ...
Escherichia coli, Escherichia coli DH5-alpha
Mol. Biosyst.
2
484-491
2006
-
-
-
-
-
-
-
-
1
-
-
-
-
15
-
-
-
-
-
-
-
-
10
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
10
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
660721
Stachyra
Fluorescence detection-based f ...
Escherichia coli
Antimicrob. Agents Chemother.
48
897-902
2004
-
1
1
-
-
-
18
-
-
-
-
1
-
1
-
-
-
-
-
-
1
-
1
-
-
-
-
-
-
-
-
-
-
-
18
-
1
1
-
-
-
-
18
18
-
-
-
-
-
1
-
-
-
-
-
-
1
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
662009
Lloyd
Phospho-N-acetyl-muramyl-penta ...
Escherichia coli
J. Bacteriol.
186
1747-1757
2004
-
-
1
-
3
-
-
-
-
-
-
1
-
2
-
-
1
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
3
-
-
-
-
-
-
-
-
1
-
-
-
1
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
662239
Bouhss
Purification and characterizat ...
Bacillus subtilis, Escherichia coli, Staphylococcus aureus, Thermotoga maritima
J. Biol. Chem.
279
29974-29980
2004
1
-
4
-
-
-
2
2
1
2
-
4
-
5
-
-
1
-
-
-
1
-
8
-
-
-
-
2
-
-
-
-
-
-
1
1
-
4
-
-
-
-
1
2
-
2
1
2
-
4
-
-
-
1
-
-
1
-
8
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
645343
Zawadzke
Targeting the MraY and MurG ba ...
Escherichia coli
Anal. Biochem.
314
243-252
2003
-
1
1
-
-
-
2
-
-
-
-
2
-
1
-
-
1
-
-
-
-
-
4
-
-
-
-
-
-
-
-
-
-
-
-
-
1
1
-
-
-
-
-
2
-
-
-
-
-
2
-
-
-
1
-
-
-
-
4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
645342
Azzolina
The cell wall and cell divisio ...
Pseudomonas aeruginosa
Protein Expr. Purif.
21
393-400
2001
-
1
1
-
-
-
-
-
2
-
-
1
-
1
-
-
1
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
-
1
1
-
-
-
-
-
-
-
-
2
-
-
1
-
-
-
1
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
645341
Bouhss
Topological analysis of the Mr ...
Escherichia coli, Staphylococcus aureus
Mol. Microbiol.
34
576-585
1999
-
-
1
-
-
-
-
-
4
-
-
2
-
4
-
-
-
-
-
-
-
-
6
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
4
-
-
2
-
-
-
-
-
-
-
-
6
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
645340
Brandish
Slow binding inhibition of pho ...
Escherichia coli, Escherichia coli JM105
J. Biol. Chem.
271
7609-7614
1996
1
-
1
-
-
1
1
3
-
2
1
2
-
8
-
-
-
-
-
-
2
-
12
-
-
-
-
-
-
-
-
-
1
-
-
1
-
1
-
-
-
1
-
1
1
3
-
2
1
2
-
-
-
-
-
-
2
-
12
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
645339
Pickup
-
Non-fragmenting variants of St ...
Streptomyces sp.
J. Ferment. Bioeng.
79
247-251
1995
-
-
-
-
-
-
1
-
1
-
-
1
-
1
-
-
-
-
-
2
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
1
-
-
1
-
-
-
-
-
2
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
645338
Ikeda
The Escherichia coli mraY gene ...
Escherichia coli, Escherichia coli Y-10
J. Bacteriol.
173
1021-1026
1991
-
-
1
-
-
-
1
-
1
-
-
2
-
5
-
-
-
-
-
-
-
-
6
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
1
-
-
1
-
-
2
-
-
-
-
-
-
-
-
6
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
645337
Kimura
-
Liposidomycin C inhibits phosp ...
Escherichia coli, Escherichia coli Y-10
Agric. Biol. Chem.
53
1811-1815
1989
-
-
-
-
-
-
1
-
-
-
-
2
-
3
-
-
-
-
-
-
-
-
4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
2
-
-
-
-
-
-
-
-
4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
645336
Tanaka
Studies on bacterial cell wall ...
Bacillus megaterium, Bacillus megaterium KM / ATCC 13632
J. Antibiot.
35
1216-1221
1982
-
-
-
-
-
-
3
1
-
1
-
2
-
14
-
-
-
-
-
-
-
-
6
-
-
-
-
-
1
1
-
-
-
-
-
-
-
-
-
-
-
-
-
3
-
1
-
1
-
2
-
-
-
-
-
-
-
-
6
-
-
-
-
-
1
1
-
-
-
-
-
-
-
-
645335
Weppner
Initial membrane reaction in p ...
Staphylococcus aureus, Staphylococcus aureus Copenhagen
Biochim. Biophys. Acta
552
418-427
1979
1
-
-
-
-
-
-
-
1
1
-
2
-
9
-
-
-
-
-
-
-
-
6
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
1
1
-
2
-
-
-
-
-
-
-
-
6
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
645334
Geis
Phospho-N-acetylmuramoyl-penta ...
Escherichia coli
Biochim. Biophys. Acta
527
414-424
1978
2
-
-
-
-
-
-
6
3
3
-
1
-
2
-
-
1
-
-
-
-
-
4
-
-
-
-
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
6
3
3
-
1
-
-
-
1
-
-
-
-
4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
645333
Hammes
On the specificity of phospho- ...
Staphylococcus aureus, Staphylococcus aureus Copenhagen
J. Biol. Chem.
249
3140-3150
1974
-
-
-
-
-
-
-
16
-
-
-
2
-
8
-
-
-
-
-
-
-
-
6
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
16
-
-
-
2
-
-
-
-
-
-
-
-
6
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
645332
Pless
Initial membrane reaction in p ...
Staphylococcus aureus, Staphylococcus aureus Copenhagen
J. Biol. Chem.
248
1568-1576
1973
2
-
-
-
-
-
-
-
-
1
-
2
-
8
-
-
-
-
-
-
-
-
6
-
-
-
-
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
-
1
-
2
-
-
-
-
-
-
-
-
6
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
645331
Umbreit
Complex lipid requirements for ...
Micrococcus luteus
Proc. Natl. Acad. Sci. USA
69
1972-1974
1972
2
-
-
-
-
-
1
-
1
-
-
1
-
1
-
-
-
-
-
-
-
-
4
-
-
-
-
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
-
1
-
-
1
-
-
1
-
-
-
-
-
-
-
-
4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
645330
Heydanek
The initial stage in peptidogl ...
Staphylococcus aureus, Staphylococcus aureus Copenhagen
Biochemistry
8
1474-1481
1969
-
-
-
-
-
1
-
-
1
-
2
4
-
8
-
-
1
-
-
-
1
1
8
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
1
-
-
-
-
1
-
2
4
-
-
-
1
-
-
1
1
8
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
645329
Struve
On the initial stage in peptid ...
Staphylococcus aureus, Staphylococcus aureus Copenhagen
Biochemistry
5
82-93
1966
-
-
-
-
-
-
2
2
-
-
-
2
-
8
-
-
-
-
-
-
-
-
4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
-
2
-
-
-
2
-
-
-
-
-
-
-
-
4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-